Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Small cell lung cancer recurrent: Which Medications Are Safest? (29 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

29 medications are used for Small cell lung cancer recurrent, with 96 combined adverse event reports. The most reported drugs for Small cell lung cancer recurrent are IRINOTECAN and AMRUBICIN.

96
Total Reports
29
Drugs Used

All Medications for Small cell lung cancer recurrent Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
IRINOTECAN Irinotecan Hydrochloride 27 4,530 10,384 16.2%
AMRUBICIN - 26 38 25 24.2%
TARLATAMAB-DLLE IMDELLTRA (AMG757) 17 103 206 12.8%
ETOPOSIDE Avopef 10 11,780 17,699 22.4%
CARBOPLATIN Carboplatin 9 12,544 35,869 14.9%
NIVOLUMAB OPDIVO 8 23,086 36,530 26.3%
DOXORUBICIN Doxorubicin Hydrochloride 7 15,653 28,630 18.9%
IPILIMUMAB YERVOY 7 8,043 17,031 22.0%
LURBINECTEDIN ZEPZELCA 7 252 337 26.1%
PACLITAXEL PACLITAXEL PACLITAXEL 6 12,030 31,638 15.6%
TOPOTECAN\TOPOTECAN - 6 150 78 29.4%
ATEZOLIZUMAB Tecentriq Hybreza 5 8,520 15,094 25.3%
PLINABULIN - 5 3 11 23.1%

View all 29 drugs →

Most Reported Drugs for Small cell lung cancer recurrent

#1 most reported
#2 most reported
#3 most reported